drugset / Trial / NCT07354269

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

NCT07354269

Phase 4 Recruiting 180 enrolled Sinovac Biotech Co., Ltd
Non-randomizedParallel-groupOpen-labelPrevention

Summary

The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months

Timeline

Start
2025-09-26
Primary completion
2026-04-11
Completion
2026-05-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pediacel® Vaccine Intramuscular
Subject inactivated poliovirus vaccine, Sabin strain Vaccine Intramuscular

Indications